Sign in

Tiffany Goolsby, PharmD, BCIDP

@tiffanygoolsby.bsky.social
189 followers 278 following 17 posts

Antimicrobial Stewardship and Infectious Diseases Pharmacist|| Subject Matter Expert for Bitscopic's clinical surveillance software, PraediAlert

PostsRepliesMedia
Tiffany Goolsby, PharmD, BCIDP @tiffanygoolsby.bsky.social · 14/05/2026
The @bitscopic.bsky.social pharmacy crew is kicking off the @sidpharm.bsky.social and @mad-id.bsky.social annual meeting! @kelechevarria.bsky.social #MADIDxSIDP2026
021
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 16/04/2026
Is your #Cdiff protocol stopping at the door? 🚪aたん2 Ep57 reveals a gap: 🔹 CDI patients sent to SNFs cost ~2x more. 🔹 SNF patients face higher mortality. Coordination is the new frontline. #PraediAlert spots trends before readmission. 🛑 Watch:
youtube.com
#57 Beyond Discharge: The Skilled Nursing Facility's Role in C. diff Management
Join Nicki and Jess as they dive into the journey of Clostridioides difficile (C. diff) infections as patients move between hospitals and Skilled Nursing Facilities (SNFs). They're joined by special guests Kelly, Glenn, and Cory, who help unpack insights from a massive U.S. study of over 86,000 hosp
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 20/04/2026
Turning guidelines into practice is where infection prevention often breaks down. At AORN26, a simple but powerful idea: make policies scalable and usable. Flexible policies = better adoption + safer care. Join the conversation --> tinyurl.com/6mzj68nz #InfectionPrevention #AORN2026 #PatientSafety
tinyurl.com
AORN26: Turning Infection Prevention Guidelines Into Practical Policies With a Scalable Framework | Infection Control Today
At AORN 2026, Erica Smith, DrPH, MBA, shares a practical framework for turning infection prevention guidelines into flexible, sustainable policies that help perioperative teams improve compliance with...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 21/04/2026
New RCT in #DFO 🦶: Bone biopsy may not be superior to ulcer bed biopsy for guiding antibiotics. Remission rates were similar at 12 months, challenging the “gold standard.” 💊 Read more: doi.org/10.1093/cid/...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 22/04/2026
Not all “susceptible” MSSA is the same. 🦠 Cefazolin inoculum effect showed up in 35.5% of isolates and was linked to more microbiologic failure, despite no mortality difference. A good stewardship reminder when MSSA isn’t clearing. doi.org/10.1093/infd...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 23/04/2026
✅ Masking/PPE efficacy ✅ Facility-specific data > Rigid mandates ✅ "Precision Prevention" Data-driven surveillance is the future. #PraediAlert Link: bit.ly/4bNC78E #InfectionControl #MRSA #PatientSafety
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 27/04/2026
Machine Learning is reshaping PK/PD modeling 🤖💊—from predicting ADME to optimizing individualized dosing. New review highlights promise and challenges (data quality, clinical integration). Big implications for precision dosing. 🔗 www.sciencedirect.co...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 05/03/2026
A recent VA presentation shows that CDC’s #ProjectFirstline education led to a 69% drop in CLABSI and 47% in CAUTI. By pairing Firstline’s training with PraediAlert’s real-time surveillance, we can turn IP into a proactive shield for our Veterans.
pmc.ncbi.nlm.nih.gov
313. Impact of a Project Firstline Educational Campaign on Hospital Acquired Infection Rates Pre/Post Intervention - PMC
Project Firstline (PFL) is a national training collaborative for healthcare infection prevention and control (IPC). PFL was created by the Centers for Disease Control and Prevention, in partnership with the American Academy of Pediatrics and the ...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 11/03/2026
“Antibiotic allergy” ≠ true allergy. ESCMID guideline: only ~5–10% of documented antibiotic allergies are immune-mediated. Use structured history; if low risk, de-label or do a supervised challenge. Big stewardship + patient-safety win.
doi.org
ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy
Antibiotic allergies remain one of the most frequently documented drug allergies in clinical records. It is well established that only a small proport…
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 16/03/2026
New MDR P. aeruginosa analysis: Ceftolozane-tazobactam showed higher cure and lower mortality vs aminoglycosides/polymyxins, with similar outcomes vs ceftazidime-avibactam. Despite newer agents, 30-day mortality remained ~22%. #AMR #ASP #ID doi.org/10.1128/aac....
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 17/03/2026
Colorectal SSI prevention: new network meta-analysis (105 RCTs; 18,273 pts) found broad-spectrum penicillins + cephalosporin-based regimens had the strongest SSI reduction; broad-spectrum penicillins also linked to lower mortality. doi.org/10.1001/jama...
doi.org
Antibiotic Prophylaxis Choice and Surgical Site Infections in Colorectal Surgery
This systematic review and network meta-analysis uses data from randomized clinical trials to compare the association of different antibiotic classes and class combinations with clinical and safety ou...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 24/02/2026
Combo hype for MRSA bacteremia?? 🦠💉 Updated meta-analysis: adding ceftaroline to vanco or dapto did not lower mortality or recurrence vs monotherapy (mostly cohort data + 1 RCT). When are you adding ceftaroline, and for how long? doi.org/10.1080/1478...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 25/02/2026
Steroids in severe pneumonia—helpful or harmful? 🫁💊 Annals On Call: when to add corticosteroids in severe CAP, expected benefit, and what to watch (glucose, delirium, secondary infections). How are you using them in your ICU? doi.org/10.7326/ANNA...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 07/01/2026
Primary care pharmacists improve diabetes outcomes: doi.org/10.1093/ajhp... PraediAlert helps pharmacists track patients, boost efficiency, and prioritize clinically relevant interventions. bitscopic.com/soluti... #PraediAlert #ClinicalPharmacy
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 08/01/2026
2026 NHSN Update: 2 big shifts for your surveillance workflow. BONE Logic: Osteomyelitis now has a 21-day window & the RIT lasts the entire admission. CLIP Retired: The CLIP module is officially gone. www.cdc.gov/nhsn/pdf... #InfectionPrevention #NHSN2026 #PatientSafety
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 13/01/2026
The CDC estimates 1–3M long-term care residents get HAIs each year. Stronger infection control protects residents, supports staff, and boosts ratings. How are you protecting your most vulnerable? #InfectionPrevention #PatientSafety #SeniorCare #EVS tinyurl.com/zwub8kxs
tinyurl.com
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 14/01/2026
⚠️ Antimicrobial Stewardship Alert: New nationwide cohort data suggest prenatal antibiotic exposure may raise neonatal GBS risk, especially in low-risk pregnancies. Read the study here: doi.org/10.1016/j.ji... #GBS #AntibioticStewardship
doi.org
Antibiotic use during pregnancy and neonatal Group B Streptococcus disease
To examine the association between prenatal antibiotic exposure and Group B Streptococcus (GBS) disease within 4 weeks postpartum.We conducted a popul…
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 15/01/2026
A new study proves that proactive, multifaceted nursing strategies lead to better maternal outcomes. PraediAlert automates surveillance, letting nurses focus on care, not spreadsheets. journals.lww.com/jnc... #DigitalHealth #SSI
journals.lww.com
Assessment of Surgical Site Infection Prevention Strategies ... : Journal of Nursing Care Quality
analysis was conducted on 200 obstetric surgical patients from January 2018 to December 2022. The observation group received comprehensive SSI prevention strategies and the control group received routine nursing care. Results: The observation group had a significantly lower SSIs rate (3.0% vs 10.0%, P = .045), fewer complications (1.0% vs 7.0%, P = .028), better incision healing (98.0% vs 91.0%, P = .028), fewer adverse events (4.0% vs 13.0%, P = .022), and lower pain scores on postoperative days 1 and 2. Conclusion: Implementing comprehensive SSI prevention strategies in obstetric nursing significantly reduces SSIs, complications, and pain, while enhancing wound healing and recovery....
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 20/01/2026
Check out APIC's latest podcast episode! From bedside to boardroom 🩺➡️🏛️ Episode #76 features Kathy Ward, RN—APIC’s 2026 President—sharing her journey, mentors, and vision for the future of infection prevention. A must-listen for rising IPC leaders. tinyurl.com/APIC-Pod...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 21/01/2026
New VA/DoD primary care CKD guidance in Ann Intern Med highlights key pharmacotherapy recommendations: ACEi/ARB for albuminuria; SGLT2i and GLP-1 RA when indicated; plus statins and clearer referral pathways. 💊💉 doi.org/10.7326/ANNA...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 26/01/2026
Gram-negative resistance is accelerating—DTR Pseudomonas, CRAB, & MBL-CRE remain major gaps. This review breaks down newly approved BL/BLIs (sulbactam/durlobactam, cefepime/enmetazobactam, aztreonam/avibactam) + key pipeline agents shaping future therapy. 🧫💊 rdcu.be/e0N5J
rdcu.be
Filling the Gaps: A Review and Update on Beta-Lactamase Inhibitor Combinations
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 27/01/2026
Influenza still poses a major global threat, driven by constant mutation and pandemic-capable zoonotic strains. New advances in vaccines, diagnostics & digital health offer hope, but early detection and coordinated response remain critical. PraediAlert can help!
bitscopic.com
PraediAlert
Discover how PraediAlert Clinical Surveillance transforms patient data into decision-ready insights for better healthcare outcomes.
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 28/01/2026
Will P-CABs replace PPIs treating GERD/PUD? 🤔💊 New systematic review/meta-analysis: overall adverse event risk looked comparable, but P-CABs raised serum gastrin (~+131 pg/mL) and warrant watching for hepatic dysfunction. Are you switching? 🔄 doi.org/10.1111/jgh....
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 19/01/2026
Can we safely stop abx in patients with a neg pna PCR panel? Possibly yes --> bit.ly/3YKU1D7 Be the first to know about PCR results through PraediAlert! bitscopic.com/solutions/pr...
bit.ly
Safety and efficacy of antimicrobial optimization based on negative results from BioFire FilmArray Pneumonia panel and respiratory culture | Antimicrobial Stewardship & Healthcare Epidemiology | C...
Safety and efficacy of antimicrobial optimization based on negative results from BioFire FilmArray Pneumonia panel and respiratory culture - Volume 5 Issue 1
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 22/12/2025
Early IV→oral switch works—and safer. In the pragmatic COPAT RCT (5 hospitals), early oral therapy cut adverse events vs IV-only (3.2% vs 6.5%; HR 0.24) with equivalent efficacy. #AntimicrobialStewardship academic.oup.com/cid/advance-...
academic.oup.com
Using the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics
Early IV to oral transition improves antibiotic treatment safety across many serious infections. In a rural health system, implementation of the COPAT Tria
075
Tiffany Goolsby, PharmD, BCIDP @tiffanygoolsby.bsky.social · 11/11/2025
Excited to work with the best! Welcome Kelly!
000
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 30/10/2025
Recurrent C. diff = financial drain and preventable patient harm. Protect your 💰 and well-being with PraediAlert which has prevention strategies like real-time alerts, antimicrobial stewardship, hand hygiene tracking. tinyurl.com/3zr75ej4 #CDiff #InfectionControl
tinyurl.com
Economic impact of multiple recurrent Clostridioides difficile infection in a community teaching hospital | Infection Control & Hospital Epidemiology | Cambridge Core
Economic impact of multiple recurrent Clostridioides difficile infection in a community teaching hospital
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 24/10/2025
Infection Prevention Week 2025: we want to recognize the incredible work IPs do every day. You are the shield between patients & the threat of infection. You educate teams & tirelessly enforce the standards that keep hospitals & communities safe. #IIPW #InfectionPrevention #Infection
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 27/10/2025
Your next sepsis data analyst might be… an LLM. A JAMA Network Open study used LLaMA 3 to parse >100k clinical notes, clustering symptoms that predicted infection source, resistance, & mortality—with 99% accuracy. 🔗 jamanetwork.com/journals/jam... #Sepsis #AI #ClinicalResearch
jamanetwork.com
Syndromic Analysis of Sepsis Cohorts Using Large Language Models
This cohort study compares the performance of a large language model against manual medical record review for extracting presenting signs and symptoms data from hospital admission notes and uses these...
021
Tiffany Goolsby, PharmD, BCIDP @tiffanygoolsby.bsky.social · 18/10/2025
@sidpharm.bsky.social
010
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 14/10/2025
A “negative” dalbavancin trial doesn’t mean a dead end—it means opportunity. @PaulSaxMD highlights why even when results aren’t what we hoped for, there’s room for optimism in innovation, stewardship, and trial design. Read more: tinyurl.com/3m9wj28k #AntibioticStewardship #Dalbavancin
tinyurl.com
DOTS: Optimism Around a “Negative” Dalbavancin Trial
The DOTS randomized clinical trial of dalbavancin versus standard-of-care for Staph aureus bacteremia (SAB) just landed in JAMA, where it undoubtedly will be featured in numerous ID, hospitalist, and medical resident journal clubs over the next several months. Proof:  one of our great second-year ID fellows tagged it immediately for his journal club literally the […]
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 01/10/2025
New data show shifts in carbapenemase-producing CRE from 2019–2023. KPC remains most common, but NDM and other metallo-β-lactamases are rising. doi.org/10.7326/ANNA... PraediAlert can help monitor resistance patterns in your facility. #AMR #PraediAlert
001
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 01/10/2025
The FDA has officially rescinded its 2024 rule on laboratory developed tests (LDTs) confirming that oversight belongs under CLIA. What does this mean for clinical labs? bitscopic.com/the-fda-back...
bitscopic.com
The FDA Backpedals on LDTs: What It Means for Clinical Labs
Understand the FDA's role in laboratory developed tests as oversight transitions back to CLIA for better lab regulation clarity.
001
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 02/10/2025
Summer's over, but the fight against HAIs continues! These are the top 5 topics from the season: + Borescopes in Sterile Processing + Risks of unauthorized UVC devices + Emerging pathogens (BOTM) + Dental assistant training & more Stay ahead of the curve:
infectioncontroltoday.com
Top 5 Infection Prevention Articles of Summer 2025
Check out the top 5 infection control and prevention articles for Summer 2025! Perennial articles like Bug of the Month and The Clean Bite, and a look at borescopes in sterile processing.
001
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 06/10/2025
🩺 Can reducing the frequency of monitoring safely lessen the burden on OPAT teams and patients? In 420 patients, only 2% had lab abnormalities linked to readmission or treatment change. academic.oup.com/ofid/article... #OPAT #AntimicrobialStewardship #IDPharmacy
academic.oup.com
Evaluation of the safety of cefazolin monotherapy in outpatient parenteral antimicrobial therapy at a large academic medical center
Abstract. In outpatient parenteral antimicrobial therapy, weekly lab monitoring is often standard practice, even for antimicrobials with low complication r
023
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 29/09/2025
🔑 HI-PRO Trial (NEJM): In pts w/ provoked VTE + enduring risk factors, 12 mo of low-dose apixaban ↓ recurrent VTE (1.3% vs 10%) vs placebo, w/ low major bleed risk. www.nejm.org/doi/full/10.... #VTE #Thrombosis #NEJM
nejm.org
Apixaban for Extended Treatment of Provoked Venous Thromboembolism | NEJM
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk f...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 25/09/2025
Research shows that educating and empowering patients can improve central line care practices. This highlights how a multi-pronged approach, from data-driven alerts to patient partnership, is crucial for preventing infections. #PraediAlert #PatientCare #DataDrivenHealthcare
ajicjournal.org
Impact of empowerment of onco-hematological patients on the incidence of catheter-related bloodstream infections
Patients with hematologic malignancies and hematopoietic stem cell transplant recipients (HSCT) are at high risk of central venous catheter-related bloodstream infections (CLABSI). Global actions have encouraged patient empowerment as a strategy to reduce these infections. We aim to evaluate the impact of patient empowerment in reducing the incidence density (ID) of CLABSI.
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 22/09/2025
🦠💊 How long should we treat bacteremia? Ep. 121 of Breakpoints podcast dives into the BALANCE trial, exploring 7 vs 14 days of antibiotics in critically ill pts. What does this mean for stewardship? Tune in: breakpoints-sidp.org... #SIDP #ASP
breakpoints-sidp.org
#121 - Finding BALANCE In Antibiotic Durations: The BALANCE Trial – Breakpoints: The SIDP Podcast
In this second-ever collaboration between SIDP’s Breakpoints and ESCMID’s Communicable podcasts, hosts Erin McCreary and Angela Huttner invite the two
011
Tiffany Goolsby, PharmD, BCIDP @tiffanygoolsby.bsky.social · 15/09/2025
Does your institution reflex to urine cultures?
010
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 25/08/2025
Should we extend the use of oral antibiotics in infective endocarditis? The ENDO-ORAL study url: academic.oup.com/cid/article/...
academic.oup.com
Should we extend the use of oral antibiotics in infective endocarditis? The ENDO-ORAL study
This real-life study showed that switching from intravenous to oral antibiotic therapy in infective endocarditis was effective and safe, including in patie
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 14/08/2025
Stay ahead of trends! The latest CDC data highlights ongoing surveillance for viruses and bacteria beyond flu, COVID-19, and RSV, like Mycoplasma pneumonia and pertussis. Use PraediAlert to quickly identify and respond to changing illness patterns in your facility.
cdc.gov
Other Respiratory Illnesses Going Around
This page details respiratory illnesses from viruses and bacteria other than COVID-19, flu, and RSV
031
Reposted by Tiffany Goolsby, PharmD, BCIDP
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 13/08/2025
Finally published 🆕🔥DOTS RCT Among participants with complicated S aureus bacteremia who achieved blood culture clearance, dalbavancin was not superior to standard therapy for achieving a more desirable outcome at day 70 #idsky jamanetwork.com/journals/jam...
2287
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 13/08/2025
Long-acting lipoglycopeptides can provide a convenient alternative to daily antibiotic infusions for enterococcal endocarditis. doi.org/10.1093/ofid... PraediAlert can help you monitor OPAT patients to ensure proper follow up care. #PraediAlert #OPAT #endocarditis
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 11/08/2025
*New* 2025 Clinical Practice Guideline Update by the IDSA on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness academic.oup.com/cid/article/... #IDsky #pharmsky
academic.oup.com
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Ill...
Abstract. As the first part of several focused updates to the clinical practice guideline on the treatment and management of COVID-19 in adults, children,
012
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 30/07/2025
While some recent studies have raised the concern that DoxyPEP leads to increased tetracycline resistance in multiple organisms, this study demonstrates a decrease in overall antibiotic use for treating STIs. doi.org/10.1093/jac/... #PharmSky #IDSky
011
Tiffany Goolsby, PharmD, BCIDP @tiffanygoolsby.bsky.social · 21/07/2025
They are finally here!
000
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 21/07/2025
The Complicated UTI Guidelines from IDSA are officially published. www.idsociety.org/pr... #IDSky
021
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 15/07/2025
The latest issue of Prevention Strategist explains how the long-term care IP can decode the antibiogram. Check it out to see how you can protect vulnerable residents through antibiotic stewardship! #NursingHome #InfectionPrevention www.preventionstrate...
preventionstrategist-digital.com
DECODING THE ANTIBIOGRAM: A Hidden Asset in Long-Term Care
It’s 10 p.m. in the long-term care...
011
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 09/07/2025
The recombinant zoster vaccine provides durable protection against shingles and post-herpetic neuralgia. doi.org/10.1093/cid/... PraediAlert can help you identify eligible patients who have not yet been vaccinated. #vaccines #IDSky
doi.org
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States
AbstractBackground. Recombinant zoster vaccine (RZV) was approved for adults aged ≥50 years in the United States to prevent herpes zoster (HZ) and postherp
021
Reposted by Tiffany Goolsby, PharmD, BCIDP
BITSCOPIC @bitscopic.bsky.social · 14/07/2025
Candida auris news has a new name -Candidozyma auris! Also, EUCAST has established clinical breakpoints. www.clinicalmicrobiologyandinfection.com/article/S119...
clinicalmicrobiologyandinfection.com
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established EUCAST breakpoints
Candida auris (Candidozyma auris) has emerged as an important pathogen across all continents, with clonal outbreaks and hospital transmissions. Most isolates are fluconazole resistant and variable res...
021